Guerrero-Ochoa, P.; Ibáñez-Pérez, R.; Berbegal-Pinilla, G.; Aguilar, D.; Marzo, I.; Corzana, F.; Minjárez-Sáenz, M.; MacÃas-León, J.; Conde, B.; Raso, J.;
et al. Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral Treatment. Biomedicines 2022, 10, 1223.
https://doi.org/10.3390/biomedicines10061223
AMA Style
Guerrero-Ochoa P, Ibáñez-Pérez R, Berbegal-Pinilla G, Aguilar D, Marzo I, Corzana F, Minjárez-Sáenz M, MacÃas-León J, Conde B, Raso J,
et al. Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral Treatment. Biomedicines. 2022; 10(6):1223.
https://doi.org/10.3390/biomedicines10061223
Chicago/Turabian Style
Guerrero-Ochoa, Patricia, Raquel Ibáñez-Pérez, Germán Berbegal-Pinilla, Diederich Aguilar, Isabel Marzo, Francisco Corzana, Martha Minjárez-Sáenz, Javier MacÃas-León, Blanca Conde, Javier Raso,
and et al. 2022. "Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral Treatment" Biomedicines 10, no. 6: 1223.
https://doi.org/10.3390/biomedicines10061223
APA Style
Guerrero-Ochoa, P., Ibáñez-Pérez, R., Berbegal-Pinilla, G., Aguilar, D., Marzo, I., Corzana, F., Minjárez-Sáenz, M., MacÃas-León, J., Conde, B., Raso, J., Hurtado-Guerrero, R., & Anel, A.
(2022). Preclinical Studies of Granulysin-Based Anti-MUC1-Tn Immunotoxins as a New Antitumoral Treatment. Biomedicines, 10(6), 1223.
https://doi.org/10.3390/biomedicines10061223